About Kevin Law
Form D filings for Phi Therapeutics in 2024 list Kevin Law as director.
Kevin Law first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Law in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Law works with at each company, as listed on that company's latest Form D.
Phi Therapeutics, Inc. · Form D/A, Jun 26, 2024
JL
Jun Li
Director
YV
Yug Varma
Executive officer and director
NG
Neil Giugno
Chief Executive Officer and director